Draig Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Maindy Road, Cardiff, Cardiff, CF24 4HQ,...Website
www.draigtherapeutics.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Draig Therapeutics
Draig Therapeutics is a clinical-stage biotechnology company based in Cardiff, Wales, focused on developing next-generation treatments for neuropsychiatric disorders.Explore more
Draig Therapeutics Org Chart
IK
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Draig Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Draig Therapeutics
Website visits: Recent activity has been detected on your website
Check if Draig Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Draig Therapeutics has new funding data
Earning: See what the market has to say on Draig Therapeutics recently announced quarterly report
Click to see if Draig Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Draig Therapeutics launches new products
Check out if Draig Therapeutics is spiking on competitors!
Draig Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Draig Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
Draig Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Draig Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Draig Therapeutics.
Draig Therapeutics financials insights
Gather financial insights about Draig Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Seed
$25.9M
Series A
$140M
2026
Series B
$65M
Most Recent Scoops
Person-Based
Funding, Pharmaceuticals, Finance
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
Project
Laboratory Operations, Medical Research, Clinical Operations
Draig Therapeutics News & Media
Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of DT-101 for the Treatment of Major Depressive Disorder
Cardiff, United Kingdom – 2 October 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces that it will initiate a Phase 2 study of DT-101, a next-generation AMPA receptor positive allosteric modulator (PAM) for Major Depressive Disorder (MDD) in the US in Q4 2025. The decision follows US Food and Drug Administration (FDA) clearance of the IND application for the Phase 2 trial protocol.Neuroscience is back!: Draig co-founder talks funds - BioXconomy
Ruth McKernan, Draig's co-founder & executive chair, shared insights into their Series A financing, Welsh roots, and the keys to their funding triumph.Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Directors. He takes over from Ruth McKernan, who retains her role on the Board as a Director and Interim Chief Executive Officer (CEO).
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Draig Therapeutics
Sign Up For FreeTo access detailed company insights
Draig Therapeutics is a clinical-stage biotechnology company based in Cardiff, Wales, focused on developing next-generation treatments for neuropsychiatric disorders.... Read More
